These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7767151)

  • 1. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial.
    Bergmann OJ; Ellermann-Eriksen S; Mogensen SC; Ellegaard J
    BMJ; 1995 May; 310(6988):1169-72. PubMed ID: 7767151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial.
    Bergmann OJ; Mogensen SC; Ellermann-Eriksen S; Ellegaard J
    J Clin Oncol; 1997 Jun; 15(6):2269-74. PubMed ID: 9196140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
    Anderson H; Scarffe JH; Sutton RN; Hickmott E; Brigden D; Burke C
    Br J Cancer; 1984 Jul; 50(1):45-9. PubMed ID: 6378236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.
    Saral R; Ambinder RF; Burns WH; Angelopulos CM; Griffin DE; Burke PJ; Lietman PS
    Ann Intern Med; 1983 Dec; 99(6):773-6. PubMed ID: 6359995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
    Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
    Lönnqvist B; Palmblad J; Ljungman P; Grimfors G; Järnmark M; Lerner R; Nyström-Rosander C; Oberg G
    Support Care Cancer; 1993 May; 1(3):139-44. PubMed ID: 8149141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpesviridae-associated persistent mucocutaneous ulcers in acquired immunodeficiency syndrome. A clinicopathologic study.
    Flaitz CM; Nichols CM; Hicks MJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Apr; 81(4):433-41. PubMed ID: 8705589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
    J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.
    Whitley RJ; Levin M; Barton N; Hershey BJ; Davis G; Keeney RE; Whelchel J; Diethelm AG; Kartus P; Soong SJ
    J Infect Dis; 1984 Sep; 150(3):323-9. PubMed ID: 6090539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation.
    Epstein JB; Ransier A; Sherlock CH; Spinelli JJ; Reece D
    Eur J Cancer B Oral Oncol; 1996 May; 32B(3):158-62. PubMed ID: 8762872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
    Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral recrudescent herpes simplex virus infection.
    Woo SB; Lee SF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Feb; 83(2):239-43. PubMed ID: 9117756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent herpes simplex labialis with oral acyclovir.
    Spruance SL; Stewart JC; Rowe NH; McKeough MB; Wenerstrom G; Freeman DJ
    J Infect Dis; 1990 Feb; 161(2):185-90. PubMed ID: 2153735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
    Rooney JF; Straus SE; Mannix ML; Wohlenberg CR; Alling DW; Dumois JA; Notkins AL
    Ann Intern Med; 1993 Feb; 118(4):268-72. PubMed ID: 8380540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of erythema multiforme associated with recurrent herpes infection: a case report.
    Osterne RL; Matos Brito RG; Pacheco IA; Alves AP; Sousa FB
    J Can Dent Assoc; 2009 Oct; 75(8):597-601. PubMed ID: 19840503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
    Paz-Bailey G; Sternberg M; Puren AJ; Markowitz LE; Ballard R; Delany S; Hawkes S; Nwanyanwu O; Ryan C; Lewis DA
    J Infect Dis; 2009 Oct; 200(7):1039-49. PubMed ID: 19715417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial.
    Raborn GW; Martel AY; Grace MG; McGaw WT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jan; 85(1):55-9. PubMed ID: 9474615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.